Descemet Endothelial Thickness Comparison Trial I

NCT05289661 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Fuchs

Interventions

DRUG: Topical Ripasudil
DRUG: Topical Placebo

Sponsor

Stanford University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]